Percutaneous Closure of Perimembranous XXXX Using the Second-Generation Amplatzer Vascular Occluders.

@entity1 @entity2003 @entity174 @entity1757 @entity997 @entity337 @entity2142 @entity3555 @entity616
UNASSIGNED: Earlier attempts at percutaneous closure of perimembranous @entity1757 (Pm  VSDs) were abandoned because of incidence of @entity616 likely as a result of @entity2003 and/or oversizing. This is retrospective review and data reporting of @entity1 who underwent percutaneous closure using the softer second-generation Amplatzer vascular occluders; namely the Amplatzer vascular plug, second generation, (AVP II) and the Amplatzer duct occluder, second generation (ADO II) in our institution. A total of 20 @entity1 were identified; AVP II was used in 9 @entity1 and ADO II in 11 @entity1 . Median weight was 13.45  kg (range 6.5 to 76); age 28.5  months (range 11 to 352). After procedure, 4 were noted to have @entity337 ; trivial in 3 and mild in 1  (unrelated  to the device). Mild @entity997 possibly device or procedure related was seen in 4. Residual flow through the device was common after procedure and disappeared in all but 3, graded as trivial in 1, small in 2. Average follow-up period was 7.54 months    7.5 (1  day to 25  months). There was no incidence of @entity616 , @entity3555 , @entity2142 , device embolization, or @entity174 . The @entity337 resolved in 1 @entity1 and was estimated to be trivial in the remaining 3 @entity1 . In conclusion, percutaneous closure of Pm VSDs using the softer new generation devices as the AVP II and the ADO II is feasible and safe. Longer follow-up and larger series are needed.
